Christopher Raymond Jones

Dr. Christopher Raymond Jones


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2012 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
CJChristopher Raymond Jones
Christopher Raymond Jones
PBPranjal K. Baruah
Pranjal K. Baruah
ATAmber L. Thompson
Amber L. Thompson
Steve ScheinerSteve Scheiner
Steve Scheiner
MSMartin D. Smith
Martin D. Smith

27 October 2017 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
FIFahima I. M. Idiris
Fahima I. M. Idiris
CJChristopher Raymond Jones
Christopher Raymond Jones
Aryne chemistry has experienced a remarkable renaissance in recent years, with a significant increase in the synthetic applications reported for these highly valuable reactive intermediates. This resurgence of interest is in part due to the introduction of ortho-silylaryl triflates as precursors which can be activated under mild conditions using fluoride. Alternative fluoride-free strategies have received interest in the last decade, with a number of precursors to arynes and their activators reported. These approaches offer alternative modes of reactivity which prove, in some cases, to be orthogonal to those of ortho-silylaryl triflates. This review highlights some of the more recent fluoride-free methodologies developed to access aryne intermediates that start from arene-based precursors.

17 September 2009 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
CJChristopher Raymond Jones
Christopher Raymond Jones
Dan PantoșDan Pantoș
Dan Pantoș
AMAngus J. Morrison
Angus J. Morrison
MSMartin D. Smith
Martin D. Smith

16 October 2019 in Chemical Science
Verified
Journal Article
Open access
PDF file
LFLe Fang
Le Fang
GTGiuseppe Trigiante
Giuseppe Trigiante
RCRachel Crespo-Otero
Rachel Crespo-Otero
CHChris Hawes
Chris Hawes
MPMichael P. Philpott
Michael P. Philpott
MWMichael Watkinson
Michael Watkinson
Two endoplasmic reticulum (ER) targeting probes were developed to image mobile Zn 2+ to help understand Zn 2+ related biological processes in the ER.

7 July 2023 in Small
Verified
Journal Article
Open access
YXYue Xu
Yue Xu
RXRuikuan Xie
Ruikuan Xie
QLQi Li
Qi Li
JFJingyu Feng
Jingyu Feng
HLHui Luo
Hui Luo
CJChristopher Raymond Jones
Christopher Raymond Jones
Pyridinic nitrogen has been recognized as the primary active site in nitrogen‐doped carbon electrocatalysts for the oxygen reduction reaction (ORR), which is a critical process in many renewable energy devices. However, the preparation of nitrogen‐doped carbon catalysts comprised of exclusively pyridinic nitrogen remains challenging, as well as understanding the precise ORR mechanisms on the catalyst. Herein, a novel process is developed using pyridyne reactive intermediates to functionalize carbon nanotubes (CNTs) exclusively with pyridine rings for ORR electrocatalysis. The relationship between the structure and ORR performance of the prepared materials is studied in combination with density functional theory calculations to probe the ORR mechanism on the catalyst. Pyridinic nitrogen can contribute to a more efficient 4‐electron reaction pathway, while high level of pyridyne functionalization result in negative structural effects, such as poor electrical conductivity, reduced surface area, and small pore diameters, that suppressed the ORR performance. This study provides insights into pyridine‐doped CNTs‐functionalized for the first time via pyridyne intermediates‐as applied in the ORR and is expected to serve as valuable inspiration in designing high‐performance electrocatalysts for energy applications.

12 December 2013 in The Journal of Organic Chemistry
Verified
Journal Article
Open access
TDTim Donohoe
Tim Donohoe
CJChristopher Raymond Jones
Christopher Raymond Jones
AKAnne F. Kornahrens
Anne F. Kornahrens
LBLuiz C. A. Barbosa
Luiz C. A. Barbosa
LWLouise J. Walport
Louise J. Walport
DBDavid B. Baker
David B. Baker
The total synthesis of (±)-streptonigrin, a potent tetracyclic aminoquinoline-5,8-dione antitumor antibiotic that reached phase II clinical trials in the 1970s, is described. Two routes to construct a key pentasubstituted pyridine fragment are depicted, both relying on ring-closing metathesis but differing in the substitution and complexity of the precursor to cyclization. Both routes are short and high yielding, with the second-generation approach ultimately furnishing (±)-streptonigrin in 14 linear steps and 11% overall yield from inexpensive ethyl glyoxalate. This synthesis will allow for the design and creation of druglike late-stage natural product analogues to address pharmacological limitations. Furthermore, assessment of a number of chiral ligands in a challenging asymmetric Suzuki–Miyaura cross-coupling reaction has enabled enantioenriched (up to 42% ee) synthetic streptonigrin intermediates to be prepared for the first time.